Genentech announced a $750 million expansion of its Hillsboro campus that is expected to create 450 manufacturing and construction jobs. The new facility will add device-filling capability to the biotechnology company’s U.S. manufacturing network, expanding an established operation in Washington County and adding capacity to Oregon’s life-sciences sector.

Key Takeaways

• Genentech announced a $750 million expansion of its Hillsboro campus.
• The project is expected to create 450 manufacturing and construction jobs.
• The new facility will add device-filling capability to Genentech’s U.S. manufacturing network.
• Genentech’s Hillsboro campus has operated since 2006 and supports production across multiple therapeutic areas.
• A forgivable loan from Oregon’s Strategic Reserve Fund will help offset initial project costs, with terms still in final contract negotiations.

Genentech Announces $750 Million Hillsboro Campus Expansion

The expansion will add a new facility to Genentech’s existing Hillsboro campus, extending the company’s manufacturing operations in Oregon. The project represents a $750 million investment and is expected to create 450 manufacturing and construction jobs.

The investment involves Genentech, a biotechnology company with an established manufacturing operation in Hillsboro, and the state of Oregon. Governor Tina Kotek and Genentech announced the expansion as part of the state’s efforts to support business investment and job creation.

The project will add device-filling capability to Genentech’s manufacturing network in the United States. The new capacity will be located at the company’s Hillsboro campus, which has been part of Genentech’s U.S. manufacturing network since 2006.

The expansion also adds to the manufacturing activity already taking place at the Hillsboro site. Genentech’s existing campus supports production across several therapeutic areas, including oncology, immunology and neurology.

The 450 expected jobs cover manufacturing and construction work connected with the expansion. The employment figure provides a direct local component to the investment, with the project adding positions associated with construction of the facility and its manufacturing operations.

Hillsboro has also attracted other major commercial investments in 2026, including the opening of a new regional restaurant location that brought additional employment and construction activity to the city. 

New Facility Adds Device-Filling Capacity

The new Hillsboro facility will add device-filling capability to Genentech’s U.S. manufacturing network. The company said the additional capacity will support domestic production and contribute to a more complete supply chain within the United States.

Device filling involves manufacturing processes associated with pharmaceutical products that are delivered through devices. Genentech’s expansion will therefore add a specific manufacturing function to its existing Hillsboro operations rather than establishing an entirely separate company presence in Oregon.

The facility will build on the infrastructure already available at the Hillsboro campus. Genentech identified the site’s existing manufacturing capabilities and skilled workforce as factors supporting the expansion.

The company also has established operations at the location dating back to 2006. That existing presence gives the new facility a direct connection to Genentech’s current manufacturing activities in Hillsboro.

The expansion covers both construction and manufacturing activity. Construction work will be associated with development of the new facility, while the completed operation will add manufacturing capacity to Genentech’s network.

The project also connects Hillsboro to Genentech’s production of therapies across multiple medical areas. The existing campus supports products associated with oncology, immunology and neurology, providing the operating base for the additional device-filling capability.

Expansion Expected to Create 450 Manufacturing and Construction Jobs

The project is expected to create 450 manufacturing and construction jobs in connection with the Hillsboro expansion. The jobs are tied to the construction of the new facility and the manufacturing operation that will be added to the campus.

The employment figure is one of the project’s direct effects in Hillsboro. Construction positions will be associated with building the expansion, while manufacturing positions will support operations at the completed facility.

The investment also adds another major capital project to Hillsboro’s established manufacturing base. Genentech’s campus has operated in the community since 2006, meaning the expansion extends an existing operation rather than creating a first-time presence for the company.

The project is part of Oregon’s broader life-sciences sector, which includes biotechnology and related manufacturing businesses. The state reported that Oregon’s life-sciences sector generated $21.2 billion in total economic impact in 2023 and supported nearly 75,000 jobs across approximately 2,500 businesses.

The sector also contributed $5.6 billion in exports in 2023. Those figures provide the economic context for the Genentech project while the Hillsboro expansion itself remains focused on the company’s manufacturing capacity and associated employment.

The 450-job figure also comes as Portland-area skilled trades face changes in the local construction pipeline. Recent reporting on the region’s electrical workforce described slower apartment development alongside continued demand for construction and infrastructure workers. 

The expansion is concentrated at the Hillsboro campus. Its employment component therefore directly links the project to Washington County’s workforce and the region’s established manufacturing infrastructure.

Hillsboro Campus Builds on Established Manufacturing Operations

Genentech established its Hillsboro campus in 2006, and the location has since served as a manufacturing hub within the company’s U.S. network. The existing operation supports production across oncology, immunology and neurology.

The new facility will add another manufacturing function to that campus. Its device-filling capability will complement the production activities already carried out at the Hillsboro location.

Genentech identified Hillsboro’s infrastructure, manufacturing capabilities and skilled workforce as factors in its decision to expand at the site. The company also pointed to the existing relationship between its Hillsboro operations and state and local community stakeholders.

The project therefore builds on an established company presence and existing manufacturing infrastructure. The expansion does not represent a relocation of the Hillsboro campus; it adds new capacity to the site.

Hillsboro’s industrial development environment includes other large-scale facilities and infrastructure projects. The city recently approved a temporary pause on new data center applications while officials review land-use regulations, although existing projects and applications already in process were excluded from the restrictions. 

For the regional economy, the project connects capital investment with manufacturing employment in Hillsboro. The 450 expected manufacturing and construction jobs provide the clearest employment component identified in the announcement.

The expansion also adds capacity to Genentech’s domestic manufacturing network. The company said the new facility will help strengthen U.S. production and support a more complete domestic supply chain.

Frequently Asked Questions

How much is Genentech investing in its Hillsboro expansion?

Genentech announced a $750 million investment in the expansion of its Hillsboro campus. The project includes a new facility that will add device-filling capability to the company’s U.S. manufacturing network.

How many jobs will the Genentech Hillsboro expansion create?

The expansion is expected to create 450 manufacturing and construction jobs. The positions are connected to construction of the new facility and its manufacturing operations.

What will Genentech’s new Hillsboro facility produce?

The new facility will add device-filling capability to Genentech’s manufacturing network. The expansion is designed to increase the company’s U.S. production capacity.

How long has Genentech operated its Hillsboro campus?

Genentech’s Hillsboro campus was established in 2006. The site supports manufacturing across therapeutic areas including oncology, immunology and neurology.

What state funding is supporting the Genentech expansion?

Oregon is using a forgivable loan from the Governor’s Strategic Reserve Fund to help offset some initial capital investment costs. The terms of the award were in final contract negotiations with Genentech when the expansion was announced.